EDWARDS LIFESCIENCES CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 89.5 USD | -1.64% |
|
-3.05% | +17.38% |
| Jul. 15 | Sector Update: Health Care Stocks Edge Lower Late Afternoon | MT |
| Jul. 15 | Sector Update: Health Care Stocks Retreat Monday Afternoon | MT |
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Calendar
2024-07-24
- Q2 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
90.99
USD
Average target price
96.28
USD
Spread / Average Target
+5.81%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +17.38% | 54.83B | |
| +2.62% | 209B | |
| +6.44% | 183B | |
| +29.61% | 158B | |
| +34.96% | 114B | |
| +3.84% | 67.29B | |
| -4.51% | 46.88B | |
| -5.77% | 38.58B | |
| +3.71% | 36.65B | |
| +19.35% | 30.09B |
- Stock Market
- Equities
- EW Stock
- News Edwards Lifesciences Corporation
- Edwards Lifesciences to Acquire Innovalve Bio Medical
